AlphaStocks
6.9
Consider Buy

Pediatrix Medical Group, Inc. (MD)

As of Sep 20, 2026, Pediatrix Medical Group, Inc. (MD) scores 6.9/10 on AlphaStocks' five-model composite, #17 of 168 Health Care stocks. At $26, MD trades 25% below its model fair value of $35.

Health Care / Health Care Services

S&P SmallCap 600

$25.93

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#17out of 168 in Health Care

Is Pediatrix Medical Group, Inc. a Good Investment in 2026?

Pediatrix Medical Group, Inc. (MD) scores 6.9 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Greenblatt Magic Formula model rates Pediatrix Medical Group, Inc. as Strong (Earnings yield 8.5% · ROC 61%). However, the Graham model rates it Caution — 25% above fair value. Pediatrix Medical Group, Inc. currently trades 25% below its estimated fair value of $35. Pediatrix Medical Group, Inc. ranks #17 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E13.4ROE18.8Market Cap2B

Estimated Fair Value

$34.7425% below

Trading below estimated fair value. P/E of 13x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

25% above fair value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Strong

Earnings yield 8.5% · ROC 61%

Frequently Asked Questions

Is Pediatrix Medical Group, Inc. (MD) a good investment?
As of Sep 20, 2026, Pediatrix Medical Group, Inc. (MD) scores 6.9/10 on AlphaStocks' five-model composite, #17 of 168 Health Care stocks. At $26, MD trades 25% below its model fair value of $35. That is a middle-of-the-pack score with no strong signal either way.
What is Pediatrix Medical Group, Inc.'s Piotroski F-Score?
Pediatrix Medical Group, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MD overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $35, MD appears undervalued. The stock currently trades 25% below its estimated fair value. Trading below estimated fair value. P/E of 13x is moderate for this quality level.
How does MD compare to other Health Care stocks?
Pediatrix Medical Group, Inc. ranks #17 out of 168 stocks in the Health Care sector, placing it in the top 10% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about MD?
AlphaStocks evaluates MD using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 6.9/10.

Similar Stocks

DVADGXLH

Compare MD with

DVA vs MDDGX vs MDLH vs MDMD vs PARR

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer